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Background: A T helper cell (TH) 17-biased response has been observed in patients with allergic asthma,
particularly in those with neutrophil accumulation in the lung. Therefore, we sought to test the hypothesis that
neutrophils might be an important source of interleukin (IL)-17 in allergic asthma.
Methods: Whole peripheral blood cells from non-asthmatic control subjects (n = 17) and patients with mild asthma
(n = 7), moderate but persistent asthma (n = 4), or acute asthma (n = 6) were analyzed for IL-17A expression in
CD177+ neutrophils. IL-17A expression was also analyzed in CD3+CD4+ and CD3+CD8+ lymphocyte populations.
Asthmatic patients were classified as allergic to fungi, indoor allergens, or other allergens (e.g., pollen) based on a
positive intradermal allergy test reaction.
Results: The percentage of CD177+ neutrophils in whole blood of asthmatic patients was higher than in healthy
controls and highest in the moderate asthma group. Furthermore, the percentage of CD177+IL-17+ neutrophils was
elevated in patients with mild asthma, whereas the CD4+ IL-17+ lymphocyte population was higher in asthmatic
patients and highest in those with moderate but persistent asthma. We also found that the four patients that were
allergic to fungi had the highest percentage of CD177+IL17+ neutrophils and CD8+IL17+ lymphocytes.
Conclusion: IL17+CD177+ Neutrophils increase in allergic asthma patients especially when allergic to fungi. This cell
population, through release of IL-17, might be contributing during the initial phase asthmatic disease and/or during
disease progression but its role has not yet been established.
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Asthma is a heterogeneous chronic inflammatory re-
spiratory disease characterized by overproduction of
mucus and airway-wall remodeling that leads to bron-
chial hyperactivity and airway obstruction [1]. Allergens
and some pathogens have been implicated in the wors-
ening of asthma [2,3], and the disease can be classified
as mild, moderate, or severe according to the magnitude
of the inflammation [4].
For many years, allergic asthma has been considered a
T helper 2 (TH2)-biased disease, characterized by eo-
sinophil infiltration and the production of the cytokines
interleukin (IL)-4, IL-5, and IL-13 [5]. A TH17-biased re-
sponse has also been observed in patients that exhibit* Correspondence: vortiz@cinvestav.mx
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distribution, and reproduction in any mediumchronic inflammation [6] and particularly in those with
severe asthma who respond poorly to steroids, where in-
flammatory cellular infiltration in the airway is primarily
due to CD4+ TH17 cells and neutrophils [7-9].
Neutrophils have been associated with the severity of
asthma [10,11]. Moreover, studies in humans have dem-
onstrated neutrophil recruitment in response to allergen
challenge that coincides with the peak of CD4+ T-cell
recruitment. The peak of eosinophil recruitment occurs
several days later [12], suggesting the importance of neu-
trophils in the pathogenesis of the disease. In addition, it
has been reported that IL-17 favors neutrophil recruit-
ment and leads to the induction of neutrophilia rather
than eosinophilia in rodents [13,14]. The numbers of
neutrophils in the sputum [9,10,15], bronchoalveolar lav-
age [12], bronchial biopsies [16,17], and peripheral blood
[18] of allergic asthmatic patients have been shown to
increase concomitantly with IL-17 levels [7,19-21].ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Characteristics of study subjects
Asthmatics Non-asthmatic
controls
Sex (female/male) 6/11 7/10
Age (y) (mean ± SEM) 22.35 ± 3.82 24.12 ± 1.38
Atopy (Nº)1 17/17 0/17





FEV1 (% predicted) 48-117 88-111
(mean ± SEM) (77.65% ±
4.77)**
(96.59% ± 1.61)
1Atopy is defined as at least one positive prick test.
**P < .01 compared to non-asthmatic controls.
Abbreviations: FEV1 Forced expiratory volume in 1 second, Ig Immunoglobulin,
SEM Standard error of the mean.
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CD8+ T cells, γδ T cells, natural killer cells, and gra-
nulocytes [22]. In addition, it has been shown that mur-
ine neutrophils release IL-17 [13,23], but no further
studies have investigated the expression and release of
IL-17A -the most common form of IL-17- from human
peripheral blood neutrophils in neither a normal state or
during disease ( e.g., allergic asthma).
In this study, we demonstrated that in fact human
neutrophils are able to express IL-17. We also observed
increased numbers of IL-17A + neutrophils in peripheral
blood of asthmatic patients particularly in those suffer-
ing from fungal allergy-associated asthma.
Methods
Patients and control subjects
We recruited 17 asthmatic patients and all of them
tested positive in the allergen skin prick test (Alerquim,
Mexico City) to at least one of following: house dust
mites, pollens, and fungi. We classified the asthma se-
verity in our patients according to Global strategy for
asthma management and prevention: GINA executive
summary 2008 [24]. In our study we only included pa-
tients who matched the mild (seven patients) or moder-
ate (four patients) categories according to GINA.
We also included acute asthma patients (six patients)
defined as those who show exacerbation in symptoms
such as wheezing, breathlessness, and chest tightness
48 hours prior to admission to the emergency depart-
ment and received only rescue medication. These pa-
tients were enrolled within 24 hours of admission to the
emergency department. Prior to the start of treatment, a
blood sample was obtained for this study. However,
three out of the six patients with acute asthma had
inhaled β2-agonist short acting bronchodilators 48 h
before their hospital admission. Patients who had an
infection process along with the exacerbation were not
included.
All subjects (asthmatic and control) were either non-
smokers or former smokers who had quit smoking for at
least 12 months. Subjects who had used corticosteroids,
long-acting β2-agonists, leukotriene antagonists, or anti-
histamines in the month preceding the study were ex-
cluded, so were subjects with history of respiratory tract
infection in the 4 weeks preceding the study. Healthy
subjects without history of allergy or bronchial symp-
toms and who tested negative in the allergen skin prick
test (Alerquim) made up the control group. Total serum
immunoglobulin E was measured in every subject as well
as the forced expiratory volume in 1 second (FEV1).
Table 1. Three different independent measurements of
FEV1 were performed with a dry spirometer (Medgraphics,
Minnesota, USA) and the optimum value was expressed as
a percentage of the predicted value. The Ethics Committeeof the Fernando Quiroz Hospital approved the study, and
each subject gave written informed consent.
Preparation of human mononuclear cells
Whole blood cells were obtained from 17 healthy volun-
teers and 17 asthmatic patients. Peripheral blood mono-
nuclear cells (PBMCs) were isolated using a differential
centrifugation gradient (Ficoll-Paque PLUS, GE Healthcare).
The PBMCs were analyzed for viability with trypan blue,
washed, and grouped into two, either for the ex-vivo stain-
ing or in vitro activation.
Cell activation
Heparinized whole blood (HWB; 500 μL) was stimulated
with 2 μg/mL ionomycin (Sigma-Aldrich) and 40 ng/mL
phorbol myristate acetate (PMA; Sigma-Aldrich) for
18 h at 37°C. PBMCs were stimulated with 200 ng/mL
ionomycin and 2 ng/mL PMA for 18 hours at 37°C. In
both cases 10 μg/mL brefeldin A (BFA; Sigma-Aldrich)
was added during the last 6 hours of culture activation.
Surface staining and intracellular cytokine detection
Cells from activated and non-activated HWB were
stained with fluorescein isothiocyanate (FITC)-conju-
gated anti-CD177 and phycoerythrin (PE)-conjugated
anti-IL-5Rα (R&D) for 20 min at 4°C. Blood erythrocytes
were lysed with lysis buffer solution (155 mM NH4C1,
10 mM KHCO3, and 0.1 mM EDTA, pH 7.3) for 15 min
at room temperature (RT). Subsequently, cells were
permeabilized using FACS Perm2 solution (BD Biosci-
ences, San Jose, CA, USA) for 10 min based on manu-
facturer recommendations. Then samples were stained
with peridinin chlorophyll-A protein (PerCP)/Cy5.5 con-
jugated anti-IL-17A (BioLegend). Finally cells were fixed
with 2% paraformaldehyde (PFA) and analyzed using a
CyAn ADP cytometer (Beckman Coulter, Inc. Indianapolis,
IN; USA). Activated and non-activated PBMCs were
stained with FITC-conjugated anti-CD-3, allophycocyanin
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CD8 for 20 min at 4°C and afterwards permeabilized,
stained for IL-17A and CD69, and fixed as described
above. Cells were washed after fixation and analyzed with
a CyAn ADP cytometer (Beckman Coulter). Isotype-
control matched mAbs (BioLegend) were used as negative
controls for each fluorochrome.Flow cytometry analysis
Neutrophils were identified according to size (forward
scatter, FSC) and complexity (side scatter, SSC) and by
the expression of CD177 (BioLegend). Eosinophils IL-
5Rα marker was used to distinguish them from neutro-
phils in HWB to further determine the percentage of
CD177+IL17+ neutrophils. IL-17 expression was also
evaluated in CD3+CD4+ and CD3+CD8+ lymphocytes
from PBMCs previously gated according to FSC and
SSC as well. CD69 was used as an activation marker for
T cells which were activated with ionomycin-PMA. Data
analysis was performed using the FlowJo 5.6.4. software.Figure 1 Peripheral blood neutrophils were identified within the gran
(side scatter) and CD177 expression. A representative dot plot and histoStatistical analysis
Distributions of continuous variables are expressed as
mean ± standard error (SEM) and median. A nonpara-
metric Mann–Whitney U test was used to compare
continuous variables, the Wilcoxon test for 2-group com-
parisons, and the Kruskal-Wallis test for multiple compar-
isons. The Friedman post hoc test was used to confirm
differences in individual groups. P values less than .05
were interpreted to indicate significance.
Results
Peripheral blood neutrophils express IL-17 and increase
in number in allergic asthma patients
The neutrophils population in HWB was analyzed by
flow cytometry according to size (forward scatter, FSC)
and complexity (side scatter, SSC) as well as the expres-
sion of CD177 (Figure 1). The percentage of neutrophils
in the whole blood of asthmatic patients was higher than
in healthy controls (P = .012; Figure 2A), and was highest
in patients with moderate asthma (P = .0001), but no dif-
ferences were observed between patients with acuteulocytes cells according to size (forward scatter), complexity
gram is shown from one patient and one healthy control.
Ramirez-Velazquez et al. Allergy, Asthma & Clinical Immunology 2013, 9:23 Page 4 of 8
http://www.aacijournal.com/content/9/1/23asthma and healthy controls (Figure 2B). We observed
that the percentage of CD177+IL-17+ neutrophils in al-
lergic asthmatic patients was higher (P = .003) when
compared to healthy controls (Figure 3A, 3B). No further
increase was observed when neutrophils were stimulated
with ionomycin/PMA (data not shown). In addition, we
found that the percentage of CD177+IL-17+ neutrophils
increased in mild (P = .01), moderate (P = .005) and acute
asthma (P = .041) in comparison to healthy controls. The
CD177+IL-17+ neutrophils percentage was highest in pa-
tients diagnosed with mild asthma, as compared to that in
those with moderate asthma (P = .0108) or acute asthma
(P = .0001). However, no significant difference was ob-
served between the latter two groups (Figure 3C).
The percentage of IL-17A+ neutrophils in peripheral
blood is higher in asthma patients with fungal allergy
We sought to determine if a specific type of allergen
preferentially activated the neutrophil response. To ad-
dress this we analyzed the percentage of CD177+ IL-17A+
neutrophils from asthmatic patients that are allergic to
specific groups of allergens based on positive intradermal
allergy test reactions. Patients were divided into two
groups: asthmatic patients allergic to fungi (Penicilium,
Rhizopus, Candida albicans, Alternaria alternata, and
Aspergillus fumigatus) and asthmatic patients allergic to
other allergens such as pollens (Lolium perenne, Fraxinus,
Liquidambar, Pinus, Quercus, Olea europeae, Amaranthus
palmeri, Prosopis, and Chenopodium album) and indoor
allergens (dust mites, dogs, cats, and cockroaches). We
found that asthmatic patients that are allergic to fungi
(4 out of 17) had a higher percentage of CD177+ IL-17+
neutrophils in their peripheral blood compared to patients
with allergic asthma that are reactive to other allergens
(P = .0001; Table 2). Figure 3D shows that patients with
mild asthma who are allergic to fungi (2 out of 6)
exhibited the highest percentage of CD177+ IL-17+ neu-
trophils as compared to those patients with mild asthma
who are allergic to other allergens (P = .029) and to
healthy controls (allergic fungal P = .0001, other allergensFigure 2 Neutrophils increase in patients with allergic asthma. (A) The
control subjects is shown. (B) Percentages of CD177+ neutrophils from pat
control non-asthmatic subjects. The asterisks indicate **P = .01, ***P = .0001& P = .04). While analyzing the numbers of neutrophils,
we observed an increase in both the percentage of cells
that express IL-17 and the number of neutrophils
(P = .006; Table 2). This data suggests a positive associ-
ation between neutrophils, fungal allergens, and asthma.
In addition, we analyzed the percentage of IL-17A+ T
cells stratified according to the two groups of allergens
in the asthmatic patients. We found that the percentage
of CD8+ IL-17+ T cells was higher in patients that are
allergic to fungi (P = .006; Table 2). On the other hand
the percentage of CD4+ IL-17A+ T cells remained un-
changed (P = .38; Table 2) even between patients allergic
to pollens and indoor allergens (data not shown).
CD4+ IL-17+ T lymphocytes increase in number according
to asthma severity
PBMCs were isolated from peripheral blood of allergic
asthma patients and healthy controls in order to identify
IL-17+ CD4+ T cells. Analysis was performed using flow
cytometry based on the expression of molecular markers
by selecting the CD4+ IL17A+ population by gating for
lymphocytes. We observed that the percentage of CD4+
IL-17A+ T cells was higher in allergic asthma patients
than in healthy controls (P = .02; Figure 4A). We found
that the percentage of CD4+ T cells was higher in all
groups (mild P = .007, moderate P = .0001, acute P = .04)
the highest being in moderate asthma patients (P = .03).
We found no difference between patients with acute
asthma and those with moderate asthma (Figure 4B).
Discussion
Multiple lines of evidence show a link between an in-
crease in neutrophil numbers and the exacerbation, pro-
gression, severity, and difficulties in the control of
asthmatic disease [9,10,15], not just at the bronchial
level but also in peripheral blood [18]. Some mediators
of these cells such as matrix metalloproteinase-9 [25],
lactoferrin [26], reactive oxygen species [27], and IL-8
[28] have been associated with poor clinical evolution of
the disease. During this study, even though only a smallpercentage of CD177+ neutrophils in allergic asthma and healthy
ients with mild, moderate, and acute asthma in comparison with
. Error bars indicate SEM.
Figure 3 Neutrophils express IL-17A. (A) Percentages of CD177+ IL-17A+ neutrophils from allergic asthma patients and healthy controls.
(B) Percentages of CD177+ cells that are IL-17A+. (C) Percentage of IL-17A+ cells stratified by the severity of allergic asthma and (D) by responses
to allergy tests in mild asthma patients. The symbols indicate *P = .04, **P = .01, ***P = .005, and &P = .001. Error bars indicate SEM., and &P = .001.
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in the percentage of neutrophils in peripheral blood
from allergic asthmatic patients. In this same group of
patients we observed an IL-17+ neutrophil subpopula-
tion increase. The highest increase in this subpopulationTable 2 Comparisons of biomarkers in patients allergic to fun
Fungal allergens
(n = 4)
CD177+ IL-17A + (%) 2.465 ± 1.716
IL-17+ TCD4+ (%) 0.405 ± 0.233
IL-17+ TCD8+ (%) 0.277 ± 0.196
Neutrophil count (mm3) 7325 ± 1656
Eosinophil count (mm3) 390.8 ± 218.3
CD4+ T cells (mm3) 347.8 ± 147.8
CD8+ T cells (mm3) 229.9 ± 56.56
Serum total IgE levels (IU/mL) 496.43 ± 294.0
FEV1 (% predicted) 83.75 ± 14.21
Data are shown as mean ± standard errors of the mean.
Abbreviations: FEV1 Forced expiratory volume in 1 second, Ig Immunoglobulin, IL Inwas seen in patients with mild asthma. This result sug-
gests that CD177+ IL-17A + neutrophils might play a
role in the early stages of the response. The difference in
the number of IL-17A+ neutrophils in the three evalu-
ated groups did not change even after cells weregal allergens and to other allergens
Other allergens (indoor and pollen allergens) P
value*(n = 13)
0.6938 ± 0.205 0.0001
0.417 ± 0.165 0.3801
0.148 ± 0.042 0.0065
3761 ± 356.0 0.0067
693.5 ± 102.7 0.2931
507.9 ± 79.41 0.4001
363.5 ± 90.93 0.0528
352.0 ± 81.82 0.0352
75.00 ± 4.99 0.1097
terleukin.
Figure 4 Percentage of CD4+ T cells expressing IL-17 (Th17) in asthmatic patients. (A) Comparison of the percentages of Th17 cells from
patients and controls. (B) Percentage of Th17 cells stratified according to disease severity. Asterisks indicate *P = .04, **P = .007, *** P = .0001. Error
bars indicate SEM.
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shown). This indicates the possible existence of neutro-
phils that have been polarized to produce IL-17A, as has
been described for CD4+ IL-17+ T cells. However, fur-
ther studies are required to evaluate whether or not
these neutrophils subpopulation express the nuclear hor-
mone receptor RORγt [22]. Recently, Tan Z et al., dem-
onstrated that Gr-1hi mouse neutrophils express RORγt
and these cells express IL-17A mRNA after stimulation
with LPS, LPS/IL-1β, or PMA/ionomycin suggesting that
these cells have the capacity to produce IL-17A. The
RORγt neutrophils appear to amplify inflammation and
damage in ischemia-reperfusion (I/R) injury. Taz Z et al.
also showed the presence of CD15hi IL-17+ neutrophils
population in peripheral blood from seven patients
who underwent partial hepatectomy. Remarkably these
CD15hi neutrophils expressing IL-17A increased upon
surgical intervention[29]. However, they are yet to prove
whether these cells express RORγt. Their results resem-
ble ours in that there is an IL-17A subpopulation of neu-
trophils in peripheral blood and that those cells might
play a role in pathogenesis thought the release of IL-17A.
However, whether this CD15hi IL-17+ neutrophil subpop-
ulation is the same as the one described by us is yet to be
determined.
We found that patients with fungal allergies (4 of 17)
had the highest number of CD177+ IL-17+ neutrophils. In
this regard, Inoue et al. reported that the use of β-glucan
from Candida albicans in the lungs of mice induces neu-
trophilic airway inflammation and the expression of differ-
ent cytokines such as IL-17 [30]. Furthermore, Werner et
al. reported that mouse neutrophils produce IL-17 in a
dectin-1-dependent manner following infection with
Aspergillus fumigatus [31]. Thus, we suggest that fungal
allergens and their derivatives might activate neutrophils
through the dectin-1 receptor, inducing IL-17 productionand contributing to bronchial inflammation during allergic
asthma.
Additionally, we observed that the numbers of CD8+
T IL-17+ cells also increased in patients with fungal
allergy asthma. Consistent with this observation, it has
been reported that neutrophils regulate the infiltration
of CD8+ T cells to the inflammation site in an animal
model for fungal airway allergy [32]. Neutrophils could
also act as antigen-presenting cells to promote IL-17
production by CD4 and CD8+ T cells [33-35].
Finally, we observed that the percentage of CD4+IL-17+
T cells in peripheral blood of patients was associated
with the severity of asthma, confirming observations de-
scribed by other groups [6-9,21,36]. We also observed
an increase of CD4+IL-17+ T cells in acute asthma,
reinforcing the importance of IL-17A in the immunopa-
thology of asthma. Furthermore, in contrast to neu-
trophils, the production of IL-17 by CD4+ T cells was
independent of the type of allergen. Importantly, Pelletier,
M et al., described a chemokine-dependent reciprocal
cross-talk between human neutrophils and Th17
cells. They described that activated neutrophils induce
chemotaxis of Th17 cells by release of CCL2 and
CCL20 chemokines. At the same time, CXCL8 is
produced by Th17 to chemoattract neutrophils. They
also found that CD15+ neutrophils and RORγt+ cells
colocalize in gut tissue from patients with Crohn
disease and synovial fluid from rheumatoid arthritis
patients [37]. It is likely that the recruitment of neutro-
phils and Th17 in response to allergen is mediated by
the chemokine cross-talk described above.
As it is now known, Th17 response is important for
host defense against extracellular bacteria and fungi by
indirectly inducing and activating neutrophils through
production of IL-17A and IL-17 F. In this context, our
study found higher percentage of IL-17+ neutrophils in
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that this cell subpopulation might be activated by fungal
allergens to release IL-17.
Conclusion
We identified a subpopulation of CD177+ IL-17A+ neu-
trophils in peripheral blood of asthmatic patients and
healthy controls. Even though we were able to appreciate
differences between asthmatic groups, due to the num-
ber of analyzed patients, it is not possible to define the
relation between this subpopulation and severity of
asthma.
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